Organon (OGN) Cash from Financing Activities (2020 - 2026)

Organon's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at -$38.0 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities rose 49.33% year-over-year to -$38.0 million; the TTM figure through Mar 2026 stood at -$524.0 million (down 42.01% YoY), while the FY2025 annual figure was -$561.0 million, down 52.45% from the prior year.
• Cash from Financing Activities was -$38.0 million for Q1 2026 at Organon, up from -$187.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of -$38.0 million in Q1 2026 to a low of -$326.0 million in Q1 2023.
• Historically, Cash from Financing Activities has averaged -$115.8 million across 5 years, with a median of -$82.0 million in 2022.
• Biggest YoY gain for Cash from Financing Activities was 91.85% in 2022; the steepest drop was 327.78% in 2022.
• A 5-year view of Cash from Financing Activities shows it stood at -$82.0 million in 2022, then rose by 6.1% to -$77.0 million in 2023, then retreated by 6.49% to -$82.0 million in 2024, then tumbled by 128.05% to -$187.0 million in 2025, then surged by 79.68% to -$38.0 million in 2026.
• The last three Cash from Financing Activities figures came in at -$38.0 million (Q1 2026), -$187.0 million (Q4 2025), and -$76.0 million (Q3 2025), per Business Quant data.